E G I D  S Y M P O S I U M

DECEMBER 4TH, 2018 | LILLE – FRANCE
5th edition: THE GUT, INCRETINS, DIABETES

STEERING COMMITTEE

PHILIPPE FROGUEL

MD, Ph D, Director of UMR CNRS 8199-University of Lille and Pasteur Institute of Lille, Director of Research Federation 3508 labex EGID and Director of equipex LIGAN Personalized Medicine and Institute of Genomics of Lille

FRANÇOIS PATTOU

Professor of surgery, University of Lille, CHU Lille Inserm

BART STAELS

Director of UMR1011 Inserm, University Lille – EGID, CHU Lille, Pasteur Institute of Lille

CONFERENCE PROGRAMME

8.30 – 9.00 AM
WELCOME COFFEE & SYMPOSIUM MATERIAL DISTRIBUTION

9.00 – 9.15 AM
INTRODUCTION AND WELCOMING

9.15 – 10.00 AM
GUT-BRAIN GLUCOSE SIGNALLING IN THE CONTROL OF ENERGY HOMEOSTASIS

GILLES MITHIEUX
Director UMR-S1213-UCBL, Director of ALECS, Inserm 1213, Faculty of Medicine Laennec

10.00 – 10.45 AM
FOOD AND TYPE 2 DIABETES: RESTORING THE MILIEU INTERIEUR

ROY TAYLOR
Professor of Medicine and Metabolism and Director, Newcastle Magnetic Resonance Centre, Newcastle University

10.45 – 11.30 AM
MICROBIOTA AND CARDIOMETABOLIC DISEASE

ALBERT K. GROEN
AMC Amsterdam & UMCG Groningen

11:30 AM – 2.30 PM
DRINK + POSTER SESSION + LUNCH

2.30 – 3.15 PM
INCRETINS, DIABETES AND CV DISEASE

NIKOLAUS MARX
Professor of Medicine / Cardiology, Head of the Department of Internal Medicine I, University Hospital Aachen

3.15 – 4.00 PM
THERAPEUTIC POTENTIAL OF MULTI-INCRETIN THERAPY – FROM MICE TO MEN

AIMO KANNT
Head, Comorbidities and Complications of Diabetes, Sanofi Diabetes Research

4.00 – 4.30 PM
NETWORKING BREAK

4.30- 5.00 PM
BEST PAPER AWARD

5.00 PM
CONCLUSION & INVITATION TO THE CHEESE AND WINE COCKTAIL

PARTNERS